Factor Problems Flashcards

1
Q

Little spontaneous bleeding, but bleeding after surgery can be heavy, not as debilitating as hemophilia A

A

Afibrinogenemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Afibrinogenemia Lab Results

A

PLT count normal
PT and PTT prolonged
Fibrinogen low
TT prolonged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Afibrinogenemia Treatment

A

Cryoprecipitate (contains factor 8 and fibrinogen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

alteration of the structure of fibrinogen, mild bleeding tendencies

A

Dysfibrinogenemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dysfibrinogenemia Lab Results

A

PLT Count normal
PT and PTT are prolonged
TT is prolonged
Fibrinogen normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

the patient is both over clotting and over fibrinolysing (most common)

A

Disseminated Intravascular Coagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clinical Classification of DIC

A

Tissue Injury, Malignancy, Obstetrical, Infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical Manifestations of DIC

A

hemorrhaging from unrelated sites and thrombosis in intravascular of major organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DIC Lab Reuslts

A
PLT low
BT prolonged
PT and PTT Prolonged
Fibrinogen low
TT prolonged 
D-dimer present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Therapy for DIC

A

Heparin, Cryo, Platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

increased fibrinolysis, urokinase

A

primary fibrinolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Primary Fibrinolysis Lab Results

A
PT and PTT would be prolonged 
Fibrinogen low
TT Prolonged 
FDP Increased
D-dimer-
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

sex-linked spontaneous bleeding into joints and muscles

A

Hemophilia A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

0-2% activity with spontaneous bleeding

A

Severe Hemophilia A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

2-5% activity with bleeding from trivial injuries

A

Moderate hemophilia A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

5-25% activity with bleeding from traumatic injuries

A

Mild Hemophilia A

17
Q

Hemophilia Lab Reuslts

A

PTT prolonged

18
Q

Factor Assay

A

.05 patient plasma and .05 normal plasma in the PTT to show that it is normal
Redo with a known depleted plasma until you see the test is prolonged
Shows the factor that is missing

19
Q

Hemophilia Treatment

A

Factor VIII concentrates
Cryo - contraindicated
Recombinant factor VII

20
Q

clinicial symptoms indistinguishable from hemophilia A

A

Hemophilia B - Christmas Disease

21
Q

Hemophilia B Treatment

A

Proplex T

recombinant VII

22
Q

easy bruising, bleeding from the gums and GI tract, heavy periods - mucosal bleeding

A

von Willebrand Disease

23
Q

most common type of von Willebrand

A

VWF and VIII:C levels reduced - 70%

24
Q

von Willebrands Lab Results

A

PTT prolonged
Ristocetin aggregation
Ristocetin cofactor assay

25
Q

Ristocetin aggregation

A

PRP with ristocetin - abnormal test = von Willebrand’s

26
Q

Ristocetin Co-Factor Assay

A

PPP with ristocetin and normal platelets to rule out Bernard Soulier’s

27
Q

vWF Disease Treatment

A

Desmopressin (constricts the vessels)

28
Q

Lupuslike Anticoagulants

A

prolonged PTT not corrected with mixing studies because of reaction against the phospholipids in the reagent

29
Q

Hypercoagulation

A

associated with the inappropriate formation of thrombi in the vasculature

30
Q

Factors of Hypercoagulation

A

Age, Immobilization, Elevated estrogens

31
Q

Types of Hypercoagulation

A

Anti Thrombin Deficiency
Protein C Deficiency
Factor V Leiden mutation
Prothrombin variant

32
Q

Protein C deficiency

A

normally inhibits factor V and VIII

33
Q

Factor V Leiden

A

most recently described genetic defects, Protein C cannot inactivate; needs PCR

34
Q

Prothrombin Variant

A

substitution of A for G at position 20210 to increase prothrombin

35
Q

COX-2

A

made in the vascular endothelium, smooth muscle and some platelets

36
Q

Plavix

A

blocks the P2Y12 ADP binding site on the platelet